Coronary Stenting and Coronary Bypass Grafting at the Same Time in a Specialty Built Operating Room
Coronary Artery Disease
About this trial
This is an interventional treatment trial for Coronary Artery Disease focused on measuring Coronary Artery Disease, PCI, Drug eluting stents, Coronary Hybrid Revascularization, Robotic CABG
Eligibility Criteria
Inclusion Criteria: Patients with class A or B1 low risk coronary artery lesion as defined by TIMI Exclusion Criteria: Contraindications to PCI which include: Occluded coronary vessels, PVD, Unable to achieve access, Fresh thrombus, Vessels <1.5mm Contraindications to Robotic Surgery which include: Buried LAD, Unable to tolerate single lung ventilation, Inability to undergo beating heart surgery, Previous surgery of the left chest cavity, Lack of intrathoracic work space, Patients requiring emergency surgery, The following patients are also excluded: Patients with coagulation disorders; inability to tolerate GIIb/III inhibitors, Patients with ventricular arrhythmias, Patients with severe non-cardiac conditions with poor prognosis, Patients with a BMI >40, Patients with an ejection fraction of <30%, Patients with chronic renal insufficiency and creatinine >200umol/L, Patients who are >85 years of age, Patients participating in any other investigational device or study drug, Patients who have had previous thoracic surgery, Patients who have a pre-op intra-aortic balloon pump, Patients who are not able to follow the protocol requirements, Patients undergoing concomitant surgery; CABG + Valve surgery
Sites / Locations
- The London Health Sciences Centre, University Hospital